SEC Form 4 · accession 0000899243-16-016230

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Mar 17, 2016

Accepted (ET)

Mar 17, 2016 · 5:31 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001576263

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Mar 17, 2016	J	375,298	$0.00	D	0	D
Common Stock^F3	holding	—	—		—	757,935	I	See Footnote

No Table II lines on this filing.

F1Reflects 375,298 shares received by Boxer Asset Management Inc. ("Boxer Management") in connection with the transfer by Boxer Capital, LLC ("Boxer Capital") on March 16, 2016 of 474,158 shares of the common stock of the issuer, pro rata for no consideration as part of an internal reorganization that was exempt under Rule 16a-9. On March 17, 2016, Boxer Management transferred 375,298 shares of the common stock of the issuer to Braslyn Ltd. ("Braslyn") for no consideration as part of an internal reorganization.
F2These securities are owned directly by Boxer Management, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) the reporting person, (iii) MVA Investors, LLC, (iv) Braslyn, (v) Joe Lewis, (vi) Christopher Fuglesang, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Neil Reisman, (x) Shehan B. Dissanayake, (xi) Peter E. Harwin, and (xii) William N. Harwin 2012 Gift Trust F/B/O Peter Harwin.
F3These securities are owned directly by Boxer Capital, and indirectly by Boxer Management and Joe Lewis, by virtue of their ownership in Boxer Capital. The reporting person disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein.